US Patent Issued to INATHERYS on June 30 for "Antibody-drug conjucates and their uses for the treatment of cancer" (French Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,625, issued on June 30, was assigned to INATHERYS (Evry Cedex, France).

"Antibody-drug conjucates and their uses for the treatment of cancer" was invented by Pierre Launay (Rueil Malmaison, France), Herve Souchet (Paris) and Coralie Belanger (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibody-drug conjugates, wherein the antibody specifically binds to TfR, the transferrin receptor, and wherein the drug is preferably chosen among a cytotoxic drug. Such antibody-drug conjugates are useful in particular in treating proliferative diseases including cancers, such as lymphoma or leukaemia."

The patent was filed...